home / stock / bysi / bysi news

BYSI News and Press, BeyondSpring Inc. From 09/27/23

Stock Information
Company Name: BeyondSpring Inc.
Stock Symbol: BYSI
Market: NASDAQ
Website: beyondspringpharma.com
Menu
BYSI BYSI Quote BYSI Short BYSI News BYSI Articles BYSI Message Board
Get BYSI Alerts

News, Short Squeeze, Breakout and More Instantly...
BYSI - BeyondSpring and Leading Cancer Center to Present Poster at SITC's 38th Annual Meeting

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative...
BYSI - BeyondSpring to Participate in the R.W. Baird's 2023 Global Healthcare Conference

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative...

BYSI - SEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai to Board of Directors

Former Director at Eli Lilly, HSBC and Mastercard Brings Almost Five Decades of Experience in Finance, Strategy and Risk Governance NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- SEED Therapeutics (the “Company”), a BeyondSpring (NASDAQ: BYSI) subsidiary and global ...

BYSI - BeyondSpring and Leading Cancer Center Present Poster Highlighting Plinabulin's Ability to Reduce Infectious Neutropenic Fever for Multiple Myeloma Patients Undergoing AHCT

NEW YORK, June 07, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative ...
BYSI - BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting

NEW YORK, May 18, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative t...

BYSI - BeyondSpring GAAP EPS of -$0.85 beats by $0.28, revenue of $1.35M misses by $14.16M

2023-04-18 17:01:18 ET BeyondSpring press release ( NASDAQ: BYSI ): FY GAAP EPS of -$0.85 beats by $0.28 . Revenue of $1.35M (flat Y/Y) misses by $14.16M . For further details see: BeyondSpring GAAP EPS of -$0.85 beats by $0.28, revenue of $1.35M misses b...

BYSI - BeyondSpring Provides Business Update and Reports Year End 2022 Financial Results

- SEED Therapeutics, a BeyondSpring Subsidiary, Achieved Milestones on the Eli Lilly Collaboration - BeyondSpring Completed Enrollment of Three Investigator-Initiated Trials (IIT) with Plinabulin in the U.S. for Multiple Cancer Indications NEW YORK, April 18, 2023 (GLOBE NEWSWIR...
BYSI - BeyondSpring Files 2022 Annual Report on Form 20-F

NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a clinical-stage global biopharmaceutical company focused on using its novel technology platform for drug discovery and development of innovative th...

BYSI - HUT, NMTR and BYSI among mid-day movers

2023-03-13 12:54:16 ET Gainers: Provention ( PRVB ) +258% . Euda Health ( EUDA ) +41% . Calliditas ( CALT ) +31% . Cipher Mining ( CIFR ) +29% . Caleminder ( CMND ) +26% . Bakkt ( BKKT ) +26% . Hut 8 Mining ( HU...

BYSI - Provention, Caleminder top healthcare gainers; Cingulate, iCAD among losers

2023-03-13 10:02:38 ET Gainers: Provention Bio PRVB +248% . Caleminder ( CMND ) +38% . Calliditas Therapeutics ( CALT ) +32% . Euda Health ( EUDA ) +22% . Seagen  ( SGEN ) +15% . Losers: Cingulate CING -28...
Previous 10 Next 10